Signal strength of reports of finasteride administration at the SOC level by Xiaoling Zhong (181270)

Subjects:

Signal strength of reports of finasteride administration in female at the PT level. by Xiaoling Zhong (181270)

Subjects:

Signal strength of reports of finasteride administration in male at the PT level. by Xiaoling Zhong (181270)

Subjects:

Signal strength of reports of finasteride administration at the PT level (age = 18-65). by Xiaoling Zhong (181270)

Subjects:

Signal strength of reports of finasteride administration at the PT level (age>=65). by Xiaoling Zhong (181270)

Subjects:

Clinical characteristics of reports with finasteride as the primary suspected drug from the FAERS database. by Xiaoling Zhong (181270)

Subjects:

Sex-differentiated risk signal volcano plot for finasteride. by Xiaoling Zhong (181270)

Subjects:

Number of adverse reaction case reports of finasteride administration at the PT level. by Xiaoling Zhong (181270)

Subjects:

CONSORT diagram. by Bon-Wook Koo (13773694)

“…<div><p>Background</p><p>Intraoperative fluid balance significantly affects patients’ outcomes. Goal-directed fluid therapy (GDFT) has reduced the incidence of major postoperative complications by 20% for 30 days after open abdominal surgery. …”

Raw data. by Bon-Wook Koo (13773694)

“…<div><p>Background</p><p>Intraoperative fluid balance significantly affects patients’ outcomes. Goal-directed fluid therapy (GDFT) has reduced the incidence of major postoperative complications by 20% for 30 days after open abdominal surgery. …”

Postoperative outcomes. by Bon-Wook Koo (13773694)

“…<div><p>Background</p><p>Intraoperative fluid balance significantly affects patients’ outcomes. Goal-directed fluid therapy (GDFT) has reduced the incidence of major postoperative complications by 20% for 30 days after open abdominal surgery. …”

Postoperative complications. by Bon-Wook Koo (13773694)

“…<div><p>Background</p><p>Intraoperative fluid balance significantly affects patients’ outcomes. Goal-directed fluid therapy (GDFT) has reduced the incidence of major postoperative complications by 20% for 30 days after open abdominal surgery. …”

Correlation in site-level DNA methylation estimates between TMS and RRBS data after permutation. by Amy Longtin (21409957)

MXene-Coated Liquid Metal Nanodroplet Aggregates by Mason Zadan (8667870)

“…In contrast to silicone-based composites containing LM droplets or MXene nanosheets alone, these MXene-LM-silicone-based composites exhibit an exponential increase in thermal and electrical conductivity with decreasing interfacial thickness with significantly lower LM volume fractions (25 vol %) while avoiding LM rupture and bleed-out. …”

MXene-Coated Liquid Metal Nanodroplet Aggregates by Mason Zadan (8667870)

“…In contrast to silicone-based composites containing LM droplets or MXene nanosheets alone, these MXene-LM-silicone-based composites exhibit an exponential increase in thermal and electrical conductivity with decreasing interfacial thickness with significantly lower LM volume fractions (25 vol %) while avoiding LM rupture and bleed-out. …”

Baseline characteristics of the participants. by Junichi Kushioka (12236447)

“…<div><p>Locomotive Syndrome (LS) is defined by decreased walking and standing abilities due to musculoskeletal issues. …”

Internal validation by cross-validation. by Junichi Kushioka (12236447)

“…<div><p>Locomotive Syndrome (LS) is defined by decreased walking and standing abilities due to musculoskeletal issues. …”

MXene-Coated Liquid Metal Nanodroplet Aggregates by Mason Zadan (8667870)

“…In contrast to silicone-based composites containing LM droplets or MXene nanosheets alone, these MXene-LM-silicone-based composites exhibit an exponential increase in thermal and electrical conductivity with decreasing interfacial thickness with significantly lower LM volume fractions (25 vol %) while avoiding LM rupture and bleed-out. …”

Flow chart of inclusion and exclusion criteria. by Ho Geol Woo (7180775)

“…Contrary to AD, treatment of VV group was significantly associated with decreased risk of VD (HR: 0.566, 95% CI: 0.382–0.841). …”

Baseline characteristics of study participants. by Ho Geol Woo (7180775)

“…Contrary to AD, treatment of VV group was significantly associated with decreased risk of VD (HR: 0.566, 95% CI: 0.382–0.841). …”